Advertisement

Omnicell, Inc. OMCL

Set alert

Price alert · OMCL

All alert types
36.41 USD -0.24 -0.65%

At close · Nov 2

36.41 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
36.41 × 2
Ask
36.42 × 2
36.23 Day range 37.59
31.75 52-week range 55.00
YTD
-19.62%
1 year
+8.46%
Open
36.78
Prev close
36.65
Mkt cap
1.66B
Vol
1.08M
Avg vol
597.23K
EPS
0.96
P/E
37.93
Div yield
0.00%
More statistics
Low
36.23
High
37.59
Forward P/E
17.98
Beta
0.89
Short ratio
6.58
Inst. own
109.15%
Dividend
0.00
Ex-div date
Earnings
Feb 4, 2027
50-d avg
34.60
200-d avg
39.03
1y target
57.71

2Y chart

Chart tools
Interval

Events in this range
  • Oct 30, 2025Earnings: 0.51; estimate 0.36; surprise 41.67%
  • Feb 5, 2026Earnings: 0.4; estimate 0.47; surprise -14.89%
  • Apr 23, 2026Rating: Wells Fargo · Overweight → Overweight
  • Apr 28, 2026Earnings: 0.55; estimate 0.33; surprise 66.67%
  • Apr 29, 2026Rating: Keybanc · Overweight → Overweight
  • Jul 30, 2026Earnings: 0.94; estimate 0.4675; surprise 101.07%
  • Jul 31, 2026Rating: Keybanc · Overweight → Overweight
  • Jul 31, 2026Rating: Wells Fargo · Overweight → Overweight
  • Aug 3, 2026Rating: Piper Sandler · Overweight → Overweight
  • Oct 29, 2026Earnings: 0.58; estimate 0.4175; surprise 38.92%
  • Oct 30, 2026Rating: Freedom Capital Markets · Buy → Buy
Signals (81)
NameDateAgo
MACD: Sell SignalNov 2, 20268 hours ago
SMA: BullishOct 6, 20263 weeks ago
MACD: Buy SignalSep 1, 20262 months ago
SMA: BearishJul 30, 20263 months ago
SMA: BearishJul 29, 20263 months ago
SMA: BullishJul 28, 20263 months ago
SMA: BullishJul 24, 20263 months ago
SMA: BearishJul 23, 20263 months ago
SMA: BearishJul 21, 20263 months ago
MACD: Sell SignalJul 21, 20263 months ago
SMA: BullishJun 30, 20264 months ago
MACD: Buy SignalJun 29, 20264 months ago
SMA: BullishJun 24, 20264 months ago
SMA: BearishJun 22, 20264 months ago
SMA: BullishJun 18, 20264 months ago
SMA: BearishJun 17, 20264 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BearishJun 10, 20264 months ago
SMA: BearishJun 10, 20264 months ago
MACD: Sell SignalMay 15, 20265 months ago
RSI: OverboughtApr 28, 20266 months ago
SMA: BullishApr 24, 20266 months ago
SMA: BullishApr 24, 20266 months ago
SMA: BearishApr 23, 20266 months ago
SMA: BearishApr 21, 20266 months ago
SMA: BullishApr 15, 20266 months ago
SMA: BullishApr 14, 20266 months ago
MACD: Buy SignalApr 1, 20267 months ago
MACD: Sell SignalMar 27, 20267 months ago
MACD: Buy SignalMar 26, 20267 months ago
RSI: OversoldMar 19, 20267 months ago
RSI: OversoldMar 13, 20267 months ago
SMA: BearishMar 12, 20267 months ago
MACD: Sell SignalMar 12, 20267 months ago
MACD: Buy SignalFeb 24, 20268 months ago
RSI: OversoldFeb 11, 20268 months ago
SMA: BearishFeb 5, 20269 months ago
RSI: OversoldFeb 5, 20269 months ago
MACD: Sell SignalJan 20, 20269 months ago
MACD: Buy SignalJan 8, 20269 months ago
RSI: OverboughtJan 5, 202610 months ago
MACD: Sell SignalDec 26, 202510 months ago
RSI: OverboughtDec 5, 202511 months ago
RSI: OverboughtDec 3, 202511 months ago
MACD: Buy SignalDec 2, 202511 months ago
MACD: Sell SignalDec 1, 202511 months ago
MACD: Buy SignalNov 25, 202511 months ago
MACD: Sell SignalNov 18, 202511 months ago
RSI: OverboughtNov 5, 202512 months ago
SMA: BullishOct 30, 20251 year ago
SMA: BullishOct 30, 20251 year ago
MACD: Buy SignalOct 21, 20251 year ago
MACD: Sell SignalOct 10, 20251 year ago
MACD: Buy SignalOct 9, 20251 year ago
MACD: Sell SignalSep 2, 20251 year ago
RSI: OverboughtAug 22, 20251 year ago
SMA: BullishJul 29, 20251 year ago
MACD: Buy SignalJul 25, 20251 year ago
MACD: Sell SignalJul 14, 20251 year ago
SMA: BearishJul 11, 20251 year ago
SMA: BullishJul 8, 20251 year ago
SMA: BearishJul 7, 20251 year ago
MACD: Buy SignalJul 1, 20251 year ago
SMA: BullishJun 27, 20251 year ago
MACD: Sell SignalJun 16, 20251 year ago
SMA: BearishJun 12, 20251 year ago
SMA: BullishJun 3, 20251 year ago
MACD: Buy SignalMay 14, 20251 year ago
MACD: Sell SignalMay 6, 20251 year ago
RSI: OversoldMay 6, 20251 year ago
MACD: Buy SignalApr 24, 20251 year ago
MACD: Sell SignalApr 8, 20251 year ago
RSI: OversoldApr 8, 20251 year ago
MACD: Buy SignalMar 21, 20251 year ago
RSI: OversoldMar 10, 20251 year ago
MACD: Sell SignalFeb 6, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BullishJan 28, 20251 year ago
MACD: Buy SignalJan 22, 20251 year ago
MACD: Sell SignalJan 8, 20251 year ago
MACD: Buy SignalJan 3, 20251 year ago

Key statistics

Market cap
1.66B
Enterprise value
1.56B
Trailing P/E
37.93
Forward P/E
17.98
PEG ratio
15.40
Price / sales
1.33
Price / book
1.27
EPS (TTM)
0.96
Beta
0.89
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
3.59%
Revenue (TTM)
1.24B
Revenue growth
-0.90%
Free cash flow
155.97M
Total cash
314.86M
Total debt
189.67M
Return on equity
3.52%
Shares outstanding
45.48M
Short % of float
8.68%
50-day average
34.60
200-day average
39.03

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 57.71 +58.5% upside
Target (low)
50.00
Target (mean)
57.71
Target (high)
70.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Feb 4, 2027

Expected Feb 4, 2027. Consensus EPS estimate 0.42286.

Earnings history

Financials — quick view

All financials
OMCL Revenue — quarterly 312.21M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
OMCL Net income — quarterly 24.29M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
OMCL EPS — quarterly 0.53
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

OMCL recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 4, 2027Dec 30, 20260.4113———
Oct 29, 2026Sep 30, 20260.41750.58+0.16+38.92%
Jul 30, 2026Jun 30, 20260.46750.94+0.47+101.07%
Apr 28, 2026Mar 31, 20260.330.55+0.22+66.67%
Feb 5, 2026Dec 31, 20250.470.40-0.07-14.89%
Oct 30, 2025Sep 30, 20250.360.51+0.15+41.67%

Upgrades / downgrades

OMCL analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Freedom Capital MarketsmainBuyBuy
Aug 3, 2026Piper SandlerreitOverweightOverweight
Jul 31, 2026Wells FargomainOverweightOverweight
Jul 31, 2026KeybancmainOverweightOverweight
Apr 29, 2026KeybancmainOverweightOverweight
Apr 23, 2026Wells FargomainOverweightOverweight

About Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
omnicell.com

News

Your note

Sign in to keep a note on OMCL — it syncs with the Stock Master app.

Insider holders

OMCL insider holders
InsiderRelationLatest transactionDateShares held
BAUER JOANNE BDirectorStock Award(Grant)May 31, 202649,922
ETTA NCHACHAChief Financial OfficerStock Award(Grant)Mar 6, 2025132,023
LIPPS RANDALL AChief Executive OfficerSaleJul 14, 20260
MANLEY COREY JOfficerSaleMay 17, 2026112,783
NJOKU NNAMDIPresidentSaleAug 16, 2026161,224
NUTT BRIAN HOfficerStock Award(Grant)Mar 31, 202623,085

Institution ownership

OMCL institution ownership
Holder% heldSharesValueReported
Blackrock Inc.16.58%7,539,602274.52MJun 29, 2026
Vanguard Portfolio Management LLC6.93%3,151,350114.74MJun 29, 2026
Wellington Management Group, LLP5.94%2,700,60398.33MJun 29, 2026
Dimensional Fund Advisors LP5.39%2,452,44389.29MJun 29, 2026
State Street Corporation4.59%2,085,72375.94MJun 29, 2026
Vanguard Capital Management LLC4.33%1,970,47271.74MJun 29, 2026

Fund ownership

OMCL fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.97%2,714,31298.83MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.01%1,368,38649.82MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.60%1,181,61343.02MSep 29, 2026
Delaware Group Equity Funds V-Nomura Small Cap Core Fund2.56%1,162,43742.32MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.18%989,97536.04MJun 29, 2026
American Century Mutual Funds, Inc.-Small Cap Growth Fund1.44%657,10023.93MJul 30, 2026
Advertisement